Log In
BCIQ
Print this Print this
 

CB2030

  Manage Alerts
Collapse Summary General Information
Company Canopus BioPharma Inc.
DescriptionAntiviral
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today